Highlights

Highlights

Neueste Storys

Filtern
  • 07.04.2015 – 13:31

    Resverlogix Corp.

    Resverlogix Receives Two Patents for RVX-208 in China

    Calgary, Alberta (ots/PRNewswire) - Resverlogix Corp. ("Resverlogix" or the "Company") announces that it has received two China patent approvals covering RVX-208. A composition of matter patent, China No. 2007 8 0052349.8 titled, "Compounds for the Prevention and Treatment of Cardiovascular Disease" was granted until February 2027. A manufacturing patent, China No. ZL 2009 8 0106586.7 titled, "Methods of Preparing ...

  • 06.04.2015 – 14:01

    Shire Pharmaceuticals Group Plc

    Shire Comments on USPTO Petitions Related to LIALDA and GATTEX

    Lexington, Massachusetts (ots/PRNewswire) - Shire plc acknowledges the two petitions filed with the U.S. Patent and Trademark Office (USPTO) on April 2nd by Hayman Capital Management regarding LIALDA(R) (mesalamine) and GATTEX(R) (teduglutide [rDNA origin]). The patents listed in the FDA Orange Book for LIALDA and GATTEX protect the innovation and value Shire brings to patients who benefit from these important medicines. ...

  • 02.04.2015 – 09:02

    EFQM

    Bringing the UN Global Compact's 10 Principles to Life

    Brussels (ots/PRNewswire) - EFQM and UNGC join forces towards Sustainable Excellence The EFQM Good Practice Competition focuses this year on identifying real and tangible examples of how organisations ensure they comply with the UNGC's 10 principles. EFQM decided to align the theme of this year's competition to support the 15th anniversary of the UN Global Compact. The competition is open to applications from any ...